Vaccine

Hospital PMI® at 55%; September 2024 Hospital ISM® Report On Business®Hospital PMI® at 55%; September 2024 Hospital ISM® Report On Business®

Hospital PMI® at 55%; September 2024 Hospital ISM® Report On Business®

TEMPE, Ariz., Oct. 7, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in September for the 13th consecutive month…

8 months ago
Senior Life Sciences Executives Launch Enovo Life Sciences, in Partnership with Warburg PincusSenior Life Sciences Executives Launch Enovo Life Sciences, in Partnership with Warburg Pincus

Senior Life Sciences Executives Launch Enovo Life Sciences, in Partnership with Warburg Pincus

NEW YORK and OORDEGEM, Belgium, Oct. 7, 2024 /PRNewswire/ -- Life sciences industry veterans, Mario Philips and Roel Gordijn, today announced…

8 months ago
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in EuropeGE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe

GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe

CHICAGO--(BUSINESS WIRE)--GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use…

8 months ago
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in EuropeGE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe

GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe

CHICAGO--(BUSINESS WIRE)--GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use…

8 months ago
IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

LAWRENCEVILLE, N.J., Oct. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) (the “Company”), a clinical-stage company in late-stage development…

8 months ago
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of…

8 months ago
Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in RwandaSabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda

Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda

[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05,…

8 months ago
Career on Purpose (Episode 1): Merck’s Skills-First ProgramCareer on Purpose (Episode 1): Merck’s Skills-First Program

Career on Purpose (Episode 1): Merck’s Skills-First Program

NORTHAMPTON, MA / ACCESSWIRE / October 4, 2024 / Episode 1 of Career On Purpose, a new podcast series from…

8 months ago
Aero Pump and Resyca Partner to Launch Ultra Soft Nasal Pump Spray, Targeting Precise Nasal Drug Delivery ApplicationsAero Pump and Resyca Partner to Launch Ultra Soft Nasal Pump Spray, Targeting Precise Nasal Drug Delivery Applications

Aero Pump and Resyca Partner to Launch Ultra Soft Nasal Pump Spray, Targeting Precise Nasal Drug Delivery Applications

Now available for licensing, Ultra Soft Nasal Pump Spray leverages innovative spray nozzle chip technology for superior nasal cavity coverage…

8 months ago
Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive ProgramsSonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

PRINCETON, NJ, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage…

8 months ago